Table 2: Neonatal outcomes of infants born to women with CHTN-meds and CHTN without meds.
|
|
With Medication |
Without Medication |
p |
|
Mother-Infant Dyads no. |
111 |
206 |
|
|
Gender (males) no. (%) |
62 (55) |
112 (54) |
NS |
|
Birthweight (g) mean ± SD |
3062 ± 603 |
3192 ± 533 |
NS |
|
Gestational age (w) mean ± SD |
38 ± 2 |
38 ± 2 |
NS |
|
All preterm no. (%) |
18 (16) |
28 (14) |
NS |
|
Full-term no. (%) |
93 (84) |
178 (86) |
NS |
|
Intrauterine Growth |
|
|
|
|
Appropriate for gestational age no. (%) |
89 (80) |
162 (79) |
NS |
|
Large for gestational age no. (%) |
11 (10) |
22 (11) |
NS |
|
Small for gestational age no. (%) |
11 (10) |
22 (11) |
NS |
|
Admission to NICU no. (%) |
18 (16) |
33 (16) |
NS |
|
Neonatal hypoglycemia no. (%) |
14 (13) |
28 (14) |
NS |
|
Infant length of stay (d) mean ± SD |
3 ± 2 |
4 ± 4 |
NS |
|
Discharged home with mother no. (%) |
101 (90) |
190 (92) |
NS |